P286 Preplanned subgroup analysis of ABCSG-12 suggests that benefits of adjuvant zoledronic acid (ZOL) are most pronounced in lowest estrogen environment

Saved in:
Bibliographic Details
Published in:Breast (Edinburgh) 2011, Vol.20, p.S69-S69
Main Authors: Gnant, M, Mlineritsch, B, Stoeger, H, Luschin-Ebengreuth, G, Heck, D, Steger, G, Jakesz, R, Singer, C, Dubsky, P, Greil, R
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0960-9776
1532-3080
DOI:10.1016/S0960-9776(11)70228-4